Jerzy Gumulka insider trades: CNS Pharmaceuticals (CNSP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jerzy reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | CNSP | ↑ Buy | 33,333 | $0.30 | $10K | Direct | Feb 6, 2024 (5d) |
| Apr 19, 2023 | CNSP | ↑ Buy | 2,500 | $1.70 | $4K | Direct | Apr 21, 2023 (2d) |
| Apr 10, 2023 | CNSP | ↑ Buy | 7,173 | $0.74 | $5K | Direct | Apr 17, 2023 (7d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CNSP insiders
Open-market trades in the last 12 months
About Jerzy Gumulka's insider trades
Jerzy Gumulka is a director at CNS Pharmaceuticals (CNSP). Since Apr 10, 2023, Jerzy has reported 3 open-market purchases worth $20K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNSP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.